Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults)

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with two (2) sites in London. <br/><br/>Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. <br/><br/>Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. <br/><br/>Link to NHS England Regions:<br/>NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).<br/><br/>As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).<br/><br/>The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the East of England. <br/><br/>Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. <br/><br/>Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. <br/><br/>Link to NHS England Regions:<br/>NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).<br/><br/>As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).<br/><br/>The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the South East. <br/><br/>Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. <br/><br/>Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. <br/><br/>Link to NHS England Regions:<br/>NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).<br/><br/>As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).<br/><br/>The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the South West. <br/><br/>Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. <br/><br/>Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. <br/><br/>Link to NHS England Regions:<br/>NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).<br/><br/>As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).<br/><br/>The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the Midlands. <br/><br/>Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. <br/><br/>Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. <br/><br/>Link to NHS England Regions:<br/>NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).<br/><br/>As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).<br/><br/>The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the North East and Yorkshire.<br/><br/>Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. <br/><br/>Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. <br/><br/>Link to NHS England Regions:<br/>NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).<br/><br/>As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).<br/><br/>The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the North West. <br/><br/>Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. <br/><br/>Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. <br/><br/>Link to NHS England Regions:<br/>NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).<br/><br/>As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).<br/><br/>The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.